These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1942649)

  • 1. Changes in plasma lipids and abnormal lipoproteins in a patient with drug-induced cholestatic hepatitis.
    Miyahara K; Kasahara N; Kondo Y; Imai Y; Matuzaki F
    Jpn J Med; 1991; 30(4):354-9. PubMed ID: 1942649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein abnormalities in cholestasis. I. Electrophoretic and ultracentrifugal analyses.
    Watanabe M
    Acta Med Okayama; 1979 Aug; 33(4):269-85. PubMed ID: 227230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoprotein-X.
    Narayanan S
    CRC Crit Rev Clin Lab Sci; 1979 Aug; 11(1):31-51. PubMed ID: 389551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholesteryl ester transfer activity in liver disease and cholestasis, and its relation with fatty acid composition of lipoprotein lipids.
    Iglesias A; Arranz M; Alvarez JJ; Perales J; Villar J; Herrera E; Lasunción MA
    Clin Chim Acta; 1996 Apr; 248(2):157-74. PubMed ID: 8740580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occurrence of an abnormal lipoprotein in patients with liver disease.
    Ross A; Murphy GM; Wilkinson PA; Mills GL; Sherlock S
    Gut; 1970 Dec; 11(12):1035-7. PubMed ID: 5511783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma lipoprotein pattern in relation to liver histology after toxic hepatitis and experimental biliary obstruction in rabbits.
    Kanaghinis T; Avgerinos A; Scliros P; Kalantzis N; Hatzioannou J; Nikolopoulou P; Anagnostou D; Katsas A; Demopoulos J; Rekoumis G; Stathakos D
    Am J Gastroenterol; 1982 Jul; 77(7):512-22. PubMed ID: 7091141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of systemic lupus erythematosus showing abnormal lipoproteins due to accompanied drug induced hepatitis].
    Miura M; Kidokoro H; Kojima E; Hirano T; Matsuzaki H; Shimizu T; Uto H; Hirano M; Oka H
    Rinsho Byori; 1990 Feb; 38(2):220-4. PubMed ID: 2329724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative determination of the abnormal lipoprotein of cholestasis, LP-X, in liver disease.
    Ritland S
    Scand J Gastroenterol; 1975; 10(1):5-15. PubMed ID: 164686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Abnormal serum lipoproteins in cholestatic viral hepatitis (author's transl)].
    Picard J; Veissiere D; Bertrand F
    Clin Chim Acta; 1974 Feb; 51(1):5-12. PubMed ID: 4362760
    [No Abstract]   [Full Text] [Related]  

  • 10. Plasma lipoproteins and apoproteins in primary biliary cirrhosis.
    Koga S; Miyata Y; Ibayashi H
    Hepatology; 1985; 5(2):286-92. PubMed ID: 3920136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein-X in patients with cirrhosis: its relationship to cholestasis and hypercholesterolemia.
    Sörös P; Böttcher J; Maschek H; Selberg O; Müller MJ
    Hepatology; 1998 Nov; 28(5):1199-205. PubMed ID: 9794902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies in cholestasis of pregnancy.
    Johnson P; Samsioe G; Gustafson A
    Acta Obstet Gynecol Scand; 1975; 54(2):105-11. PubMed ID: 166548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High plasma cholesterol in drug-induced cholestasis is associated with enhanced hepatic cholesterol synthesis.
    Chisholm JW; Nation P; Dolphin PJ; Agellon LB
    Am J Physiol; 1999 May; 276(5):G1165-73. PubMed ID: 10330007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma lipoprotein changes in experimental cholestasis in the dog.
    Danielsson B; Ekman R; Johansson BG; Petersson BG
    Clin Chim Acta; 1977 Oct; 80(1):157-70. PubMed ID: 198165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ticlopidine-induced severe cholestatic hepatitis.
    Wu MS; Chan P; Lien GS; Cheng YS; Pan S
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Aug; 63(8):663-6. PubMed ID: 10969455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies in cholestasis of pregnancy. IV. Serum lipids and lipoproteins in relation to duration of symptoms and severity of the disease, and fatty acid composition of lecithin in relation to duration of symptoms.
    Johnson P
    Acta Obstet Gynecol Scand; 1975; 54(4):307-13. PubMed ID: 1199699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parameters of lipoprotein metabolism and cholestasis in healthy and cholestatic infants and children.
    Bojanovski M; Lükermann R; Schulz-Falten J; Sturm E; Burdelski M; Bojanovski D
    Prog Lipid Res; 1991; 30(2-3):295-300. PubMed ID: 1823948
    [No Abstract]   [Full Text] [Related]  

  • 18. Appearance and characterization of lipoprotein X during continuous intralipid infusions in the neonate.
    Griffin E; Breckenridge WC; Kuksis A; Bryan MH; Angel A
    J Clin Invest; 1979 Dec; 64(6):1703-12. PubMed ID: 227938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of plasma and liver cholesterol- and lipoprotein-metabolism determinants in LpX formation in the mouse.
    Bravo I; Amigo L; Cohen DE; Nervi F; Rigotti A; Francone O; Zanlungo S
    Biochim Biophys Acta; 2007 Jun; 1770(6):979-88. PubMed ID: 17399905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ticlopidine-induced cholestatic hepatitis with anti-nuclear antibody in serum.
    Tsai MH; Tsai SL; Chen TC; Liaw YF
    J Formos Med Assoc; 2000 Nov; 99(11):866-9. PubMed ID: 11155780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.